NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Ourobionics

Ourobionics

Private
WageningenHealthcare & Life Scienceshttps://www.ourobionics.com/

Last Round

Seed

Jan 30, 2024

Company Overview

Ourobionics is a biotechnology company that develops advanced 4D biofabrication and cyborganic technologies to create complex human tissue models for drug discovery, regenerative medicine, and medical research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, 3D Printing, Drug Discovery, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

4D bioprintingbiofabricationtissue engineeringorgan-on-a-chipin-vitro testinghuman tissue modelscyborganicdrug discoveryanimal testing alternativesbiosensorsbioelectronicspreclinical testingregenerative medicinelab-grown tissuebiomaterials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ourobionics Comparables

Compare Ourobionics with similar companies based on industry and business-model similarity.

Ourobionics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vital3D Technologies
84%
Brinter
84%
BIO INX
81%

Ourobionics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 30, 2024
AcceleratorOct 29, 2021

Key People

Founding team and executive leadership

Stephen Gerard Gray

Founder & Executive Director (COO CSO)

Founding Team

John Zandbergen

CEO & Co-Founder

Founding Team

Ali Leylavi Shoushtari

Chief Technology Officer

Executive Team

Ourobionics Investors

Notable investors and investment history

Ourobionics investors
InvestorRounds
NXTGEN HightechSeed
Hello TomorrowAccelerator
East Netherlands Development Agency (Oost NL)Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 14, 2025

    Monthly visitors increased 397% MoM.

Ourobionics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ourobionics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ourobionics's valuation, stock price, and market status.

Firmographic Details

HeadquartersWageningen
Employee Range9
Year Founded2021
Last FundingJan 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.